BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 11593336)

  • 1. Selection of drug-resistant transduced cells with cytosine nucleoside analogs using the human cytidine deaminase gene.
    Beauséjour CM; Eliopoulos N; Momparler L; Le NL; Momparler RL
    Cancer Gene Ther; 2001 Sep; 8(9):669-76. PubMed ID: 11593336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug resistance to 5-aza-2'-deoxycytidine, 2',2'-difluorodeoxycytidine, and cytosine arabinoside conferred by retroviral-mediated transfer of human cytidine deaminase cDNA into murine cells.
    Eliopoulos N; Cournoyer D; Momparler RL
    Cancer Chemother Pharmacol; 1998; 42(5):373-8. PubMed ID: 9771951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human cytidine deaminase as an ex vivo drug selectable marker in gene-modified primary bone marrow stromal cells.
    Eliopoulos N; Al-Khaldi A; Beauséjour CM; Momparler RL; Momparler LF; Galipeau J
    Gene Ther; 2002 Apr; 9(7):452-62. PubMed ID: 11938460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retroviral transfer and long-term expression of human cytidine deaminase cDNA in hematopoietic cells following transplantation in mice.
    Eliopoulos N; Bovenzi V; Le NL; Momparler LF; Greenbaum M; Létourneau S; Cournoyer D; Momparler RL
    Gene Ther; 1998 Nov; 5(11):1545-51. PubMed ID: 9930308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to cytosine arabinoside by retrovirally mediated gene transfer of human cytidine deaminase into murine fibroblast and hematopoietic cells.
    Momparler RL; Eliopoulos N; Bovenzi V; Létourneau S; Greenbaum M; Cournoyer D
    Cancer Gene Ther; 1996; 3(5):331-8. PubMed ID: 8894252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexpression of cytidine deaminase and mutant dihydrofolate reductase by a bicistronic retroviral vector confers resistance to cytosine arabinoside and methotrexate.
    Beauséjour CM; Le NL; Létourneau S; Cournoyer D; Momparler RL
    Hum Gene Ther; 1998 Nov; 9(17):2537-44. PubMed ID: 9853520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexpression of rat glutathione S-transferase A3 and human cytidine deaminase by a bicistronic retroviral vector confers in vitro resistance to nitrogen mustards and cytosine arabinoside in murine fibroblasts.
    Létourneau S; Palerme JS; Delisle JS; Beauséjour CM; Momparler RL; Cournoyer D
    Cancer Gene Ther; 2000 May; 7(5):757-65. PubMed ID: 10830723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic activity of 2',2'-difluorodeoxycytidine, 5-aza-2'-deoxycytidine and cytosine arabinoside in cells transduced with deoxycytidine kinase gene.
    Beauséjour CM; Gagnon J; Primeau M; Momparler RL
    Biochem Biophys Res Commun; 2002 May; 293(5):1478-84. PubMed ID: 12054682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mice transduced with double-mutant dihydrofolate reductase-cytidine deaminase fusion gene attained protection from high dose chemotherapy].
    Lu P; Lu Y; Pang K; Wang SB; Chen JQ; Xu HM; Wang JK; Zhao SC
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):998-1001. PubMed ID: 16194358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forced expression of cytidine deaminase confers resistance to cytosine arabinoside and gemcitabine.
    Neff T; Blau CA
    Exp Hematol; 1996 Sep; 24(11):1340-6. PubMed ID: 8862446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological approach for optimization of the dose schedule of 5-Aza-2'-deoxycytidine (Decitabine) for the therapy of leukemia.
    Momparler RL; Côté S; Eliopoulos N
    Leukemia; 1997 Mar; 11 Suppl 1():S1-6. PubMed ID: 9130684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of a novel double-mutant dihydrofolate reductase-cytidine deaminase fusion gene confers resistance to both methotrexate and cytosine arabinoside.
    Sauerbrey A; McPherson JP; Zhao SC; Banerjee D; Bertino JR
    Hum Gene Ther; 1999 Oct; 10(15):2495-504. PubMed ID: 10543614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene amplification of human cytidine deaminase proviral cDNA and increased levels of its mRNA produces enhanced drug resistance to cytosine arabinoside in retroviral-transduced murine fibroblasts.
    Beauséjour CM; Momparler RL
    Cancer Lett; 1999 Jan; 135(1):29-36. PubMed ID: 10077218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfection of murine fibroblast cells with human cytidine deaminase cDNA confers resistance to cytosine arabinoside.
    Momparler RL; Laliberté J; Eliopoulos N; Beauséjour C; Cournoyer D
    Anticancer Drugs; 1996 May; 7(3):266-74. PubMed ID: 8791999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprotection of murine hematopoietic cells by combined gene transfer of cytidine deaminase (CDD) and multidrug resistance 1 gene (MDR1).
    Brennig S; Lachmann N; Buchegger T; Hetzel M; Schambach A; Moritz T
    J Exp Clin Cancer Res; 2015 Dec; 34():148. PubMed ID: 26651614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate selection of long-term culture initiating cells following transduction of CD34(+) cells with a retrovirus containing a mutated human dihydrofolate reductase gene.
    Takebe N; Xu LC; MacKenzie KL; Bertino JR; Moore MA
    Cancer Gene Ther; 2002 Mar; 9(3):308-20. PubMed ID: 11896448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2'-deoxycytidine.
    Lemaire M; Momparler LF; Raynal NJ; Bernstein ML; Momparler RL
    Cancer Chemother Pharmacol; 2009 Feb; 63(3):411-6. PubMed ID: 18398609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive overexpression of the cytidine deaminase gene confers resistance to cytosine arabinoside in vitro.
    Schröder JK; Kirch C; Flasshove M; Kalweit H; Seidelmann M; Hilger R; Seeber S; Schütte J
    Leukemia; 1996 Dec; 10(12):1919-24. PubMed ID: 8946931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased resistance to gemcitabine (2',2'-difluorodeoxycitidine) of cytosine arabinoside-resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidine kinase.
    Bergman AM; Pinedo HM; Jongsma AP; Brouwer M; Ruiz van Haperen VW; Veerman G; Leyva A; Eriksson S; Peters GJ
    Biochem Pharmacol; 1999 Feb; 57(4):397-406. PubMed ID: 9933028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cytarabine and decitabine in combination in human leukemic cell lines.
    Qin T; Youssef EM; Jelinek J; Chen R; Yang AS; Garcia-Manero G; Issa JP
    Clin Cancer Res; 2007 Jul; 13(14):4225-32. PubMed ID: 17634552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.